{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:08:19Z","timestamp":1794254899578,"version":"4.9.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Referring to a broad spectrum of the autonomic symptoms, autonomic disorders, and general dysfunction of the autonomic nervous system, dysautonomia is one of the common and under-recognized comorbidities of a wide variety of systemic disease, including diabetes, autoimmune disorders, vitamin deficiencies, and hormonal dysregulation. The most common autonomic disorders encountered in clinical practice are postural orthostatic tachycardia syndrome (POTS), neurocardiogenic syncope (NCS), and orthostatic hypotension (OH), which may be undiagnosed or often mislabeled with psychiatric disorders. Typical clinical features of dysautonomia, such as orthostatic dizziness\/lightheadedness, orthostatic intolerance, palpitations, exercise intolerance, cognitive dysfunction, and fatigue, should prompt a diagnostic investigation for dysautonomia, which includes an in-office 10-min stand test or a tilt table test in conjunction with other autonomic function tests if available. Treatment approach consists of non-pharmacologic and pharmacologic therapies with beta blockers, midodrine, ivabradine, pyridostigmine, fludrocortisone, stimulants, and other medications. In clinical setting, dysautonomia may present a diagnostic and therapeutic challenge in patients with various systemic disorders and may require a high index of suspicion on the part of the clinician. Importantly, diagnosing and treating dysautonomia is critical to providing comprehensive and personalized medical care to complex patients with chronic illness, who are typically highly symptomatic with multi-systemic complaints as a result of comorbid, and often undiagnosed, dysautonomia.<\/jats:p>","DOI":"10.1007\/s12026-025-09661-2","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T22:36:55Z","timestamp":1751927815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Dysautonomia: a common comorbidity of systemic disease"],"prefix":"10.1007","volume":"73","author":[{"given":"Svetlana","family":"Blitshteyn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"9661_CR1","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.hrthm.2015.03.029","volume":"12","author":"RS Sheldon","year":"2015","unstructured":"Sheldon RS, Grubb BP 2nd, Olshansky B, et al. 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015;12:e41\u201363.","journal-title":"Heart Rhythm"},{"key":"9661_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s10286-011-0119-5","volume":"21","author":"R Freeman","year":"2011","unstructured":"Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Clin Auton Res. 2011;21:69\u201372. https:\/\/doi.org\/10.1007\/s10286-011-0119-5.","journal-title":"Clin Auton Res"},{"issue":"1","key":"9661_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10286-020-00749-3","volume":"31","author":"EE Benarroch","year":"2021","unstructured":"Benarroch EE. \u201cDysautonomia\u201d: a plea for precision. Clin Auton Res. 2021;31(1):27\u20139. https:\/\/doi.org\/10.1007\/s10286-020-00749-3.","journal-title":"Clin Auton Res"},{"issue":"3","key":"9661_CR4","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/jce.16117","volume":"35","author":"M St\u00e5hlberg","year":"2024","unstructured":"St\u00e5hlberg M, Mahdi A, Johansson M, Fedorowski A, Olshansky B. Cardiovascular dysautonomia in postacute sequelae of SARS-CoV-2 infection. J Cardiovasc Electrophysiol. 2024;35(3):608\u201317. https:\/\/doi.org\/10.1111\/jce.16117.","journal-title":"J Cardiovasc Electrophysiol"},{"key":"9661_CR5","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11910-023-01307-w","volume":"23","author":"S Blitshteyn","year":"2023","unstructured":"Blitshteyn S. Dysautonomia, hypermobility spectrum disorders and mast cell activation syndrome as migraine comorbidities. Curr Neurol Neurosci Rep. 2023;23:769\u201376. https:\/\/doi.org\/10.1007\/s11910-023-01307-w.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"1","key":"9661_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/pmrj.12894","volume":"14","author":"S Blitshteyn","year":"2022","unstructured":"Blitshteyn S, Whiteson JH, Abramoff B, et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022;14(1):270\u20131291. https:\/\/doi.org\/10.1002\/pmrj.12894.","journal-title":"PM R"},{"key":"9661_CR7","doi-asserted-by":"publisher","first-page":"1476918","DOI":"10.3389\/fneur.2024.1476918","volume":"15","author":"P Novak","year":"2024","unstructured":"Novak P, Systrom DM, Witte A, Marciano SP. Orthostatic intolerance with tachycardia (postural tachycardia syndrome) and without (hypocapnic cerebral hypoperfusion) represent a spectrum of the same disorder. Front Neurol. 2024;15:1476918. https:\/\/doi.org\/10.3389\/fneur.2024.1476918.","journal-title":"Front Neurol"},{"key":"9661_CR8","doi-asserted-by":"publisher","first-page":"1490744","DOI":"10.3389\/fneur.2024.1490744","volume":"15","author":"S Blitshteyn","year":"2024","unstructured":"Blitshteyn S, Treisman GJ, Ruhoy IS, Saperstein DS, Schofield JR, Goodman BP, Davenport TE, Cutchins AC, Grubb BP. Postural orthostatic tachycardia syndrome and other common autonomic disorders are not functional neurologic disorders. Front Neurol. 2024;15:1490744. https:\/\/doi.org\/10.3389\/fneur.2024.1490744.","journal-title":"Front Neurol"},{"key":"9661_CR9","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.mayocp.2012.10.013","volume":"87","author":"DM Sletten","year":"2012","unstructured":"Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated composite autonomic symptom score. Mayo Clin Proc. 2012;87:1196\u2013201.","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"9661_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/joim.12895","volume":"286","author":"BH Shaw","year":"2019","unstructured":"Shaw BH, Stiles LE, Bourne K, Green EA, Shibao CA, Okamoto LE, Garland EM, Gamboa A, Diedrich A, Raj V, Sheldon RS, Biaggioni I, Robertson D, Raj SR. The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019;286(4):438\u201348. https:\/\/doi.org\/10.1111\/joim.12895.","journal-title":"J Intern Med"},{"key":"9661_CR11","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.jacc.2021.06.045","volume":"78","author":"BH Natelson","year":"2021","unstructured":"Natelson BH, Brunjes DL, Mancini D. Chronic fatigue syndrome and cardiovascular disease: JACC State-of-the-Art review. J Am Coll Cardiol. 2021;78:1056\u201367. https:\/\/doi.org\/10.1016\/j.jacc.2021.06.045.","journal-title":"J Am Coll Cardiol"},{"key":"9661_CR12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/s41598-023-27581-9","volume":"13","author":"T Zetterman","year":"2023","unstructured":"Zetterman T, Markkula R, Miettinen T, et al. Heart rate variability responses to cognitive stress in fibromyalgia are characterised by inadequate autonomous system stress responses: a clinical trial. Sci Rep. 2023;13:700. https:\/\/doi.org\/10.1038\/s41598-023-27581-9.","journal-title":"Sci Rep"},{"key":"9661_CR13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1097\/MEG.0000000000000740","volume":"28","author":"HA Penny","year":"2016","unstructured":"Penny HA, Aziz I, Ferrar M, et al. Is there a relationship between gluten sensitivity and postural tachycardia syndrome? Eur J Gastroenterol Hepatol. 2016;28:1383\u20137. https:\/\/doi.org\/10.1097\/MEG.0000000000000740.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"9661_CR14","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1177\/0961203315587566","volume":"24","author":"S Blitshteyn","year":"2015","unstructured":"Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015;24:1364\u20139. https:\/\/doi.org\/10.1177\/0961203315587566.","journal-title":"Lupus"},{"key":"9661_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3390\/diseases10040111","volume":"10","author":"D Gala","year":"2022","unstructured":"Gala D, Scharf S, Kudlak M, et al. A comprehensive review of the neurological manifestations of celiac disease and its treatment. Diseases. 2022;10:111. https:\/\/doi.org\/10.3390\/diseases10040111.","journal-title":"Diseases"},{"key":"9661_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1212\/CON.0000000000000817","volume":"26","author":"EE Benarroch","year":"2020","unstructured":"Benarroch EE. Physiology and pathophysiology of the autonomic nervous system. Continuum (Minneap Minn). 2020;26:12\u201324. https:\/\/doi.org\/10.1212\/CON.0000000000000817.","journal-title":"Continuum (Minneap Minn)"},{"key":"9661_CR17","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrendo.2012.189","volume":"8","author":"VA Pavlov","year":"2012","unstructured":"Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex\u2013linking immunity and metabolism. Nat Rev Endocrinol. 2012;8:743\u201354. https:\/\/doi.org\/10.1038\/nrendo.2012.189.","journal-title":"Nat Rev Endocrinol"},{"key":"9661_CR18","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1186\/s13075-014-0504-2","volume":"16","author":"G Pongratz","year":"2014","unstructured":"Pongratz G, Straub RH. The sympathetic nervous response in inflammation. Arthritis Res Ther. 2014;16:504. https:\/\/doi.org\/10.1186\/s13075-014-0504-2.","journal-title":"Arthritis Res Ther"},{"key":"9661_CR19","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3390\/jpm14080799","volume":"14","author":"TE Davenport","year":"2024","unstructured":"Davenport TE, Blitshteyn S, Clague-Baker N, Davies-Payne D, Treisman GJ, Tyson S. Long Covid is not a functional neurologic disorder. Journal of Personalized Medicine. 2024;14:799. https:\/\/doi.org\/10.3390\/jpm14080799.","journal-title":"Journal of Personalized Medicine"},{"key":"9661_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.autneu.2018.04.004","volume":"215","author":"BP Goodman","year":"2018","unstructured":"Goodman BP. Evaluation of postural tachycardia syndrome (POTS). Auton Neurosci. 2018;215:12\u20139.","journal-title":"Auton Neurosci"},{"key":"9661_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1024\/0301-1526\/a000003","volume":"39","author":"H Heidrich","year":"2010","unstructured":"Heidrich H. Functional vascular diseases: raynaud\u2019s syndrome, acrocyanosis and erythromelalgia. Vasa. 2010;39:33\u201341. https:\/\/doi.org\/10.1024\/0301-1526\/a000003.","journal-title":"Vasa"},{"key":"9661_CR22","doi-asserted-by":"publisher","first-page":"102637","DOI":"10.1016\/j.autneu.2020.102637","volume":"224","author":"AJ Miller","year":"2020","unstructured":"Miller AJ, Stiles LE, Sheehan T, et al. Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome. Auton Neurosci. 2020;224: 102637. https:\/\/doi.org\/10.1016\/j.autneu.2020.102637.","journal-title":"Auton Neurosci"},{"key":"9661_CR23","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2500\/aap.2021.42.210022","volume":"42","author":"E Wang","year":"2021","unstructured":"Wang E, Ganti T, Vaou E, Hohler A. The relationship between mast cell activation syndrome, postural tachycardia syndrome, and Ehlers-Danlos syndrome. Allergy Asthma Proc. 2021;42:243\u20136. https:\/\/doi.org\/10.2500\/aap.2021.42.210022.","journal-title":"Allergy Asthma Proc"},{"key":"9661_CR24","doi-asserted-by":"publisher","first-page":"E378","DOI":"10.1503\/cmaj.211373","volume":"194","author":"SR Raj","year":"2022","unstructured":"Raj SR, Fedorowski A, Sheldon RS. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;194:E378\u201385. https:\/\/doi.org\/10.1503\/cmaj.211373.","journal-title":"CMAJ"},{"key":"9661_CR25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tcm.2021.10.007","volume":"33","author":"AF Grubb","year":"2023","unstructured":"Grubb AF, Grubb BP. Postural orthostatic tachycardia syndrome: new concepts in pathophysiology and management. Trends Cardiovasc Med. 2023;33:65\u20139. https:\/\/doi.org\/10.1016\/j.tcm.2021.10.007.","journal-title":"Trends Cardiovasc Med"},{"key":"9661_CR26","doi-asserted-by":"publisher","first-page":"6747","DOI":"10.3390\/jcm13226747","volume":"13","author":"KZ Trimble","year":"2024","unstructured":"Trimble KZ, Switzer JN, Blitshteyn S. Exercise in postural orthostatic tachycardia syndrome: focus on individualized approach. J Clin Med. 2024;13:6747.","journal-title":"J Clin Med"},{"issue":"8","key":"9661_CR27","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/imj.13093","volume":"46","author":"HS Abed","year":"2016","unstructured":"Abed HS, Fulcher JR, Kilborn MJ, Keech AC. Inappropriate sinus tachycardia: focus on ivabradine. Intern Med J. 2016;46(8):875\u201383. https:\/\/doi.org\/10.1111\/imj.13093.","journal-title":"Intern Med J"},{"issue":"3","key":"9661_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/CRD.0000000000000503","volume":"32","author":"K Dixit","year":"2024","unstructured":"Dixit K, Frishman WH. Postural tachycardia syndrome and COVID-19: focus on ivabradine therapy. Cardiol Rev. 2024;32(3):279\u201384. https:\/\/doi.org\/10.1097\/CRD.0000000000000503.","journal-title":"Cardiol Rev"},{"key":"9661_CR29","unstructured":"NIH opens long COVID trials to evaluate treatments for autonomic nervous system dysfunction. National Institutes of Health, News Release; 2024. https:\/\/www.nih.gov\/news-events\/news-releases\/nih-opens-long-covid-trials-evaluate-treatments-autonomic-nervous-system-dysfunction. Accessed 15 June 2025."},{"key":"9661_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10840-017-0225-y","volume":"48","author":"M Ruzieh","year":"2017","unstructured":"Ruzieh M, Baugh A, Dasa O, Parker RL, Perrault JT, Renno A, Karabin BL, Grubb B. Effects of intermittent intravenous saline infusions in patients with medication-refractory postural tachycardia syndrome. J Interv Card Electrophysiol. 2017;48:255\u201360. https:\/\/doi.org\/10.1007\/s10840-017-0225-y.","journal-title":"J Interv Card Electrophysiol"},{"issue":"2","key":"9661_CR31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.jacep.2023.10.015","volume":"10","author":"S Stavrakis","year":"2024","unstructured":"Stavrakis S, Chakraborty P, Farhat K, Whyte S, Morris L, Abideen Asad ZU, Karfonta B, Anjum J, Matlock HG, Cai X, Yu X. Noninvasive vagus nerve stimulation in postural tachycardia syndrome: a randomized clinical trial. JACC Clin Electrophysiol. 2024;10(2):346\u201355. https:\/\/doi.org\/10.1016\/j.jacep.2023.10.015.","journal-title":"JACC Clin Electrophysiol"},{"issue":"2","key":"9661_CR32","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/17423953221076984","volume":"19","author":"K Zha","year":"2023","unstructured":"Zha K, Brook J, McLaughlin A, Blitshteyn S. Gluten-free diet in postural orthostatic tachycardia syndrome (POTS). Chronic Illn. 2023;19(2):409\u201317. https:\/\/doi.org\/10.1177\/17423953221076984.","journal-title":"Chronic Illn"},{"issue":"8","key":"9661_CR33","first-page":"e43426","volume":"15","author":"SJ Stallkamp Tidd","year":"2023","unstructured":"Stallkamp Tidd SJ, Cantrell C, Greene BD, Wilson R. Low-dose naltrexone use in postural orthostatic tachycardia syndrome: a case series. Cureus. 2023;15(8):e43426.","journal-title":"Cureus"},{"issue":"2","key":"9661_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/15360288.2025.2456279","volume":"39","author":"A Spargo","year":"2025","unstructured":"Spargo A, Gonser L, Faley B. Evaluation of low-dose naltrexone for chronic pain management. J Pain Palliat Care Pharmacother. 2025;39(2):319\u201322. https:\/\/doi.org\/10.1080\/15360288.2025.2456279.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"11","key":"9661_CR35","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.3390\/v16111795","volume":"16","author":"A Livieratos","year":"2024","unstructured":"Livieratos A, Gogos C, Akinosoglou K. Beyond antivirals: alternative therapies for long COVID. Viruses. 2024;16(11):1795. https:\/\/doi.org\/10.3390\/v16111795.","journal-title":"Viruses"},{"key":"9661_CR36","doi-asserted-by":"publisher","unstructured":"Blitshteyn S, Funez-dePagnier G, Szombathy A, Hutchinson M. Immunotherapies for postural orthostatic tachycardia syndrome, other common autonomic disorders and long COVID: current state and future direction. Preprints. 2025; 2025041175. https:\/\/doi.org\/10.20944\/preprints202504.1175.v1","DOI":"10.20944\/preprints202504.1175.v1"},{"key":"9661_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00415-022-11344-z","volume":"270","author":"K Kesterson","year":"2023","unstructured":"Kesterson K, Schofield J, Blitshteyn S. Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS). J Neurol. 2023;270:233\u20139. https:\/\/doi.org\/10.1007\/s00415-022-11344-z.","journal-title":"J Neurol"},{"key":"9661_CR38","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1097\/MJT.0000000000000778","volume":"26","author":"JR Schofield","year":"2019","unstructured":"Schofield JR, Chemali KR. Intravenous immunoglobulin therapy in refractory autoimmune dysautonomias: a retrospective analysis of 38 patients. Am J Ther. 2019;26:570\u201382. https:\/\/doi.org\/10.1097\/MJT.0000000000000778.","journal-title":"Am J Ther"},{"key":"9661_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10286-024-01020-9","volume":"34","author":"S Vernino","year":"2024","unstructured":"Vernino S, Hopkins S, Bryarly M, Hernandez RS, Salter A. Randomized controlled trial of intravenous immunoglobulin for autoimmune postural orthostatic tachycardia syndrome (iSTAND). Clin Auton Res. 2024;34:153\u201363.","journal-title":"Clin Auton Res"},{"key":"9661_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-024-01087-4","author":"KR Ch\u00e9mali","year":"2024","unstructured":"Ch\u00e9mali KR, Blitshteyn S, Perez JA, Schofield JF. iSTAND trial of IVIG in POTS: a step in the right direction, but more studies are needed. Clin Auton Res. 2024. https:\/\/doi.org\/10.1007\/s10286-024-01087-4.","journal-title":"Clin Auton Res"},{"key":"9661_CR41","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/jpm14101063","volume":"14","author":"S Blitshteyn","year":"2024","unstructured":"Blitshteyn S, Ruhoy I. New challenges and perspectives in neurology and autonomic disorders: a leap forward. J Pers Med. 2024;14:1063. https:\/\/doi.org\/10.3390\/jpm14101063.","journal-title":"J Pers Med"},{"key":"9661_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12941-025-00793-9","volume":"24","author":"AG Ewing","year":"2025","unstructured":"Ewing AG, Joffe D, Blitshteyn S, et al. Long COVID clinical evaluation, research and impact on society: a global expert consensus. Ann Clin Microbiol Antimicrob. 2025;24:27.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"9661_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/ijerph22020275","volume":"22","author":"NJ Smyth","year":"2025","unstructured":"Smyth NJ, Blitshteyn S. Language matters: what not to say to patients with long COVID, myalgic encephalomyelitis\/chronic fatigue syndrome, and other complex chronic disorders. Int J Environ Res Public Health. 2025;22:275.","journal-title":"Int J Environ Res Public Health"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-025-09661-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-025-09661-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:29:45Z","timestamp":1770190185000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-025-09661-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["9661"],"URL":"https:\/\/doi.org\/10.1007\/s12026-025-09661-2","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None required for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SB serves on the Executive Committee for CSL Behring. SB\u00a0serves as a non-paid member on the NIH RECOVER-TLC Neurological Agents Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"105"}}